Chindex International Inc.

7201 Wisconsin Ave.

Year founded: 1981

Industry: Health Care

Post 200 Category: Top 125 Companies

Revenue: $101.58 Million

Net Income/Loss: ($3,943,000.00)

Earnings per share: ($0.74)

Dividend: n/a

Stockholder equity: $21.05 Million

Auditor: BDO Seidman LLP

Stock: CHDX

Assets: $52.09 Million

Market capitalization: $31.56 Million

52-week high: 14.5 4/14/2004

52-week low: 5.65 8/11/2004

President and CEO: Roberta Lipson

EVP: Lawrence Pemble

Employees: 759

Local employees: 17

Description: Chindex provides Western health care products and services in China. It operates a hospital in Beijing and one in Shanghai, serving mainly expatriates and well-to-do locals.

Developments: Chindex, which bills itself as the largest independent U.S. distributor in China, is still feeling the effects of the 2003 severe acute respiratory syndrome outbreak. The epidemic led to new government approval procedures that contributed to the delay in the opening of Chindex's second hospital in Shanghai. The hospital, scheduled to open last summer, opened in October. Its medical equipment division, which sells Johnson & Johnson and Siemens Medical Solutions brand devices, and its health care products division also posted losses. But during 2004, revenue began returning to pre-SARS levels. The company also raised $13.5 million through the sale of 1.5 million shares to institutional investors. Chindex used the money to complete the Shanghai facility, to introduce Chindex-branded personal-care products to retail pharmacies and to expand distribution channels for the medical equipment business. Chindex officials remained optimistic about future growth and were moving ahead with plans for a third hospital in Xiamen, a wealthy coastal city where many foreign corporations have offices. In February of this year, a German subsidiary of Chindex also won a $6.5 million contract to supply medical equipment to hospitals in two Chinese provinces.